Palvella Therapeutics, Inc. (PVLA) Shares Outstanding (Diluted Average) (2020 - 2022)
Palvella Therapeutics (PVLA) has disclosed Shares Outstanding (Diluted Average) for 5 consecutive years, with $1.8 million as the latest value for Q3 2024.
- On a quarterly basis, Shares Outstanding (Diluted Average) rose 43.22% to $1.8 million in Q3 2024 year-over-year; TTM through Sep 2024 was $1.8 million, a 43.22% increase, with the full-year FY2021 number at $64.5 million, up 18.48% from a year prior.
- Shares Outstanding (Diluted Average) was $1.8 million for Q3 2024 at Palvella Therapeutics, roughly flat from $1.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $73.9 million in Q2 2022 to a low of $1.0 million in Q2 2023.
- A 5-year average of $39.9 million and a median of $54.2 million in 2020 define the central range for Shares Outstanding (Diluted Average).
- Peak YoY movement for Shares Outstanding (Diluted Average): plummeted 98.63% in 2023, then soared 74.57% in 2024.
- Palvella Therapeutics' Shares Outstanding (Diluted Average) stood at $54.5 million in 2020, then increased by 18.48% to $64.5 million in 2021, then rose by 14.52% to $73.9 million in 2022, then crashed by 98.33% to $1.2 million in 2023, then surged by 43.22% to $1.8 million in 2024.
- Per Business Quant, the three most recent readings for PVLA's Shares Outstanding (Diluted Average) are $1.8 million (Q3 2024), $1.8 million (Q2 2024), and $1.8 million (Q1 2024).